Effect of Exercise on Tapering Antipsychotics in Patients With Psycho-cardiological Diseas
Psycho-Cardiological Disease studies the complex links between the cardiovascular system and emotions. The two diseases are now the focus of public health organizations, forming a vicious circle of mutual influence. Anxiety and depressive symptoms are three to four times more common in patients with cardiovascular dise
| Condition(s) | Cardiovascular Diseases (CVD), Depression Anxiety Disorder |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Psycho-Cardiological Disease studies the complex links between the cardiovascular system and emotions. The two diseases are now the focus of public health organizations, forming a vicious circle of mutual influence. Anxiety and depressive symptoms are three to four times more common in patients with cardiovascular disease than in the general population, and about 15 to 18 percent of patients with coronary heart disease also have major depression, while 25 to 30 percent show significant depressive symptoms. At least 20% of patients with chronic heart failure have some degree of depression. In addition, the probability of cardiovascular events is 2.5 times higher in patients with two hearts, the risk of recurrence of cardiovascular events is heightened, and is strongly associated with higher |
| Who can participate | Inclusion Criteria: 1. Diagnosed with depression/anxiety; 2. Continued use of SSris and SNris for six months prior to study start; 3. Aged between 18 and 70; 4. Confirmed cardiovascular disease (such as chronic stable coronary heart disease, heart failure, cardiomyopathy, arrhythmia, valvular heart disease, cardiac surgery, cardiac intervention, ischemia with non-obstructive coronary artery disease, etc.); 5. The patients voluntarily participated in the study, signed a written informed consent, and were willing to cooperate with the follow-up. Exclusion Criteria: 1. currently has mania or hypomania, or a history of bipolar disorder and any mental disorders (current and previous); 2. organic brain injury, etc., or serious non-cardiovascular system diseases (such as advanced cancer); 3. Unab |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Lead sponsor | Guangdong Provincial People's Hospital |
| Locations | Guangzhou, Guangdong, China |
| Start date | 2025-04-22 |
| NCT ID | NCT07025590 |
| Official listing | https://clinicaltrials.gov/study/NCT07025590 |